In line with this observation, an oligoclonal CD8+ effector T-cell population, that expands along with CLL progression and controls disease development, was observed in both CLL patients and mice bearing a CLL-like disease (90). The gene discussed is CD8A; the disease is B-cell chronic lymphocytic leukemia.